Mechanisms and environmental factors that underlying the intensification of 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy)-induced serotonin syndrome in rats

被引：0

作者：

Rui Tao

Ibrahim M. Shokry

John J. Callanan

H. Daniel Adams

Zhiyuan Ma

机构：

[1] Florida Atlantic University,Charles E. Schmidt College of Medicine

[2] Ross University,School of Veterinary Medicine

来源：

Psychopharmacology | 2015年 / 232卷

关键词：

MDMA; Serotonin syndrome; Neurotoxicity; 5-HT; receptors; 5-HT; receptors; Hyperthermia; Microdialysis; EEG;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：1245 / 1260

页数：15

共 50 条

[31] Acute psychological effects of 3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") are attenuated by the serotonin uptake inhibitor citalopram
Liechti, ME
Baumann, C
Gamma, A
Vollenweider, FX
NEUROPSYCHOPHARMACOLOGY, 2000, 22 (05) : 513 - 521
[32] The pharmacology of the acute hyperthermic response that follows administration of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') to rats
Mechan, AO
Esteban, B
O'Shea, E
Elliott, JM
Colado, MI
Green, AR
BRITISH JOURNAL OF PHARMACOLOGY, 2002, 135 (01) : 170 - 180
[33] Of mice and men on MDMA: A translational comparison of the neuropsychobiological effects of 3,4-methylenedioxymethamphetamine ('Ecstasy')
Aguilar, Maria A.
Garcia-Pardo, Maria P.
Parrott, Andrew C.
BRAIN RESEARCH, 2020, 1727
[34] Cannabis and ecstasy/MDMA (3,4-methylenedioxymethamphetamine): an analysis of their neuropsychobiological interactions in recreational users
Parrott, A. C.
Milani, R. M.
Gouzoulis-Mayfrank, E.
Daumann, J.
JOURNAL OF NEURAL TRANSMISSION, 2007, 114 (08) : 959 - 968
[35] Hypothyroidism alters striatal dopamine release mediated by 3,4-methylenedioxymethamphetamine (MDMA, ecstasy)
Peterson, AL
Gilman, TL
Banks, ML
Sprague, JE
SYNAPSE, 2006, 59 (05) : 317 - 319
[36] Cognitive performance in (±) 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") users:: a controlled study
McCann, UD
Mertl, M
Eligulashvili, V
Ricaurte, GA
PSYCHOPHARMACOLOGY, 1999, 143 (04) : 417 - 425
[37] Cognitive performance in (±) 3,4-methylenedioxymethamphetamine (MDMA, “ecstasy”) users: a controlled study
U. D. McCann
Melissa Mertl
Victoria Eligulashvili
George A. Ricaurte
Psychopharmacology, 1999, 143 : 417 - 425
[38] Fluoxetine pretreatment effects pharmacokinetics of 3,4-methylenedioxymethamphetamine (MDMA, ECSTASY) in rat
Upreti, Vijay V.
Eddington, Natalie D.
JOURNAL OF PHARMACEUTICAL SCIENCES, 2008, 97 (04) : 1593 - 1605
[39] Caffeine provokes adverse interactions with 3,4-methylenedioxymethamphetamine (MDMA, ecstasy') and related psychostimulants: mechanisms and mediators
Vanattou-Saifoudine, N.
McNamara, R.
Harkin, A.
BRITISH JOURNAL OF PHARMACOLOGY, 2012, 167 (05) : 946 - 959
[40] MDMA (3,4-methylenedioxymethamphetamine) or ecstasy: The neuropsychobiological implications of taking it at dances and raves
Parrott, AC
NEUROPSYCHOBIOLOGY, 2004, 50 (04) : 329 - 335

← 1 2 3 4 5 →